×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Loan Against Mutual Fund
Apply Now
Gold Loan
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Vouchers
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Eco Pulse
Elections 2026
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Global Wealth Summit
Unlocking opportunities in Metal and Mining
Mutual Fund Summit
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
IPL 2026
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
PF
Forum
Videos
you are here:
Home
News
Aurobindo Pharma
Aurobindo Pharma
Stocks to Watch Today: Shree Cement, Varun Beverages, Swan Defence, Strides Pharma, Tech Mahindra, Wipro, Ceigall, Aurobindo Pharma in focus on 18 March
Chartist Talk: Sudeep Shah flags deeper correction risk as Nifty breaks 61.8% Fibonacci level; suggests two stocks
Trade Spotlight: How should you trade Biocon, BlueStone Jewellery, Hero MotoCorp, Emcure, Aurobindo Pharma, and others on March 11?
Trade Spotlight: How should you trade Avenue Supermarts, Glenmark, Bharat Dynamics, Torrent Pharma, Cummins India, and others on March 10?
Stocks to Watch Today: Aurobindo Pharma, Niva Bupa, Brigade, Escorts Kubota, Hero MotoCorp, Hyundai Motor, Tata Motors, Clean Max, Accord Transformer in focus on 2 March
Buy Aurobindo Pharma; target of Rs 1390: Motilal Oswal
Stocks to Watch Today: Fractal Analytics, AYE, Manappuram, Alkem Labs, Zydus Life, Jubilant Pharmova, Fortis Healthcare, Azad Engineering, Precision Wires in focus on 16 February
Buy Aurobindo Pharma; target of Rs 1300: Prabhudas Lilladher
Aurobindo Pharm Standalone December 2025 Net Sales at Rs 2,747.28 crore, down 5.81% Y-o-Y
Aurobindo Pharm Consolidated December 2025 Net Sales at Rs 8,645.90 crore, up 8.36% Y-o-Y
Aurobindo Pharma receives 11 observations from USFDA; stock price flat
Stocks to Watch Today: SBI, Aurobindo Pharma, Ipca Labs, Tata Steel, PFC, REC, Force Motors, Kalyan Jewellers, JK Tyre, Ram Ratna Wires, Atul Auto in focus on 09 February
Buy Aurobindo Pharma; target of Rs 1430: Motilal Oswal
Chartist Talk: Sudeep Shah bets on Indus Towers, Nestle India, City Union Bank for Budget day
Trade Spotlight: How should you trade Pidilite, Fortis Healthcare, Sun Pharma, Emcure, Tata Consumer Products, and others on January 7?
Stocks to Watch Today: South Indian Bank, Hyundai Motor, Hero MotoCorp, TVS Motor, RailTel, Aurobindo Pharma, Time Technoplast, MCX in focus on 2 January
Trade Spotlight: How should you trade Ramco Cements, BSE, Aurobindo Pharma, Tech Mahindra, APL Apollo Tubes, and others on December 19?
Stocks to Watch Today: Wakefit, Corona Remedies, Dr Reddys Labs, Wipro, Aurobindo Pharma, NLC India, Ashoka Buildcon, KEC in focus on 15 December
Buy Aurobindo Pharma; target of Rs 1430: Motilal Oswal
Aurobindo Pharma incurring loss at China Plant; hopes to achieve break-even by Q4
Trade Spotlight: How should you trade Tata Communications, SAIL, Aurobindo Pharma, Samvardhana Motherson, Five-Star, and others on November 14?
Buy Aurobindo Pharma; target of Rs 1350: Motilal Oswal
Aurobindo Pharm Standalone September 2025 Net Sales at Rs 2,789.72 crore, down 1.23% Y-o-Y
Trade Spotlight: How should you trade Tech Mahindra, Aurobindo Pharma, Garden Reach, Bharat Forge, M&M, and others on November 12?
Buy Aurobindo Pharma; target of Rs 1350: ICICI Securities
View More
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio